BIOMAT Database Logo BIOMAT Database Logo

Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART. 2007

Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Department of Clinical Sciences, Malmo University Hospital, Lund University, Malmo, Sweden.

In patients co-infected with HIV-1 and GB virus C (GBV-C), the disappearance of GBV-C RNA has been associated with accelerated disease progression. We studied longitudinal GBV-C viral titres in 28 HIV-1/GVB-C co-infected individuals receiving HAART. During HAART, median GBV-C RNA titres increased from 95 to 6000 copies/ml (P < 0.001). In patients interrupting HAART, GBV-C-RNA titres decreased as HIV replication resumed. These findings further support the theory that GBV-C replication could depend on the dynamics of HIV progression.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
May 2003, Journal of medical virology,
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
January 2005, Antiviral therapy,
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
February 2006, AIDS (London, England),
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.
October 2012, Journal of acquired immune deficiency syndromes (1999),
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients.
December 2002, AIDS (London, England),
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy.
January 1999, Lancet (London, England),
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Beneficial effect of GB virus C co-infection in Human Immunodeficiency Virus type 1-infected individuals.
January 2007, Microbiology and immunology,
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Impact of hepatitis C virus coinfection on HAART in HIV-infected individuals: multicentric observation cohort.
June 2010, Journal of acquired immune deficiency syndromes (1999),
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Activation of virus replication after vaccination of HIV-1-infected individuals.
December 1995, The Journal of experimental medicine,
Per Björkman, and Leo Flamholc, and Vilma Molnegren, and Aline Marshall, and Nuray Güner, and Anders Widell
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial.
November 2005, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!